Bone Regulators and Osteoporosis Therapy, 1st ed. 2020 Handbook of Experimental Pharmacology Series, Vol. 262
Coordonnateur : Stern Paula H.
This volume is designed to provide an understanding of current and potential therapies for osteoporosis. The opening chapter introduces the cells of bone and their interactions. Several following chapters describe factors affecting bone including systemic hormones with significant effects on bone, and local mediators including growth factors, prostaglandins, cytokines and chemokines. Topics that have commanded particular attention recently are calcium, FGF-23, nervous system bone interactions. Drugs that cause bone loss provide important information on mechanism as well as therapeutic considerations. An overview of the genetics of bone disorders and a discussion of the pathophysiology of osteoporosis establish the clinical context. The final chapters discuss current and potential osteoporosis treatments.
Provides an understanding of the mechanisms by which multiple factors and therapeutic agents affect bones
Gives an overview of the genetics of bone disorders and discusses the pathophysiology of osteoporosis
Maximizes insights in current and potential osteoporosis therapies and treatments
Date de parution : 11-2021
Ouvrage de 518 p.
15.5x23.5 cm
Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).
Prix indicatif 158,24 €
Ajouter au panierDate de parution : 11-2020
Ouvrage de 518 p.
15.5x23.5 cm
Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).
Prix indicatif 158,24 €
Ajouter au panierThèmes de Bone Regulators and Osteoporosis Therapy :
Mots-clés :
Bone; Bone cell regulators; Osteoporosis; Therapy; Bone disorders; Cytokines; metabolic disease; Receptors